How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients.

Hannu KokkiMartin MaaroosSten EllamJari HalonenIlkka OjanperäMerja RantaVeli-Pekka RantaAleksandra TolonenOscar LindbergMatias ViitalaJuha Hartikainen

Published in: European journal of clinical pharmacology (2018)

The bioavailability of metoprolol by mouth was markedly reduced in the early phase after CABG with no difference between the CECC-, MECC-, and OPCAB-groups.

Keyphrases

coronary artery bypass
percutaneous coronary intervention
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
minimally invasive
peritoneal dialysis
coronary artery bypass grafting
acute coronary syndrome